Molecular biology of opioid receptors: recent advances
- PMID: 9650823
- DOI: 10.1159/000097349
Molecular biology of opioid receptors: recent advances
Abstract
Endogenous opioid peptides and opiates like morphine produce their pharmacological effects through the membrane bound opioid receptors. These receptors belong to a superfamily of G-protein-coupled receptors, all of which possess seven membrane-spanning regions. Structure-activity relationship studies of opioids opened up new avenues for the pharmacological characterization of the opioid receptors. As a further advancement in this direction, molecular cloning has led to the identification of three different types of opioid receptors -- OP1 (delta), OP2 (kappa) and OP3 (mu) -- thereby supporting the results of earlier pharmacological studies which postulated their existence. The three opioid receptors are highly homologous. Consequent to the development of highly specific and selective agonists and antagonists, it was proposed that the three types of opioid receptors could be further categorized into different subtypes. However, the molecular biology data generated so far do not support the presence of the various subtypes of the three well-characterized opioid receptors. Recent strides towards the advancement of our knowledge relating to the molecular biology of these receptors have been reviewed in this article.
Similar articles
-
Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine.Br J Pharmacol. 2002 Feb;135(3):741-50. doi: 10.1038/sj.bjp.0704527. Br J Pharmacol. 2002. PMID: 11834622 Free PMC article.
-
Peptide and nonpeptide ligands for opioid receptors.Acta Pol Pharm. 1995 Sep-Oct;52(5):349-63. Acta Pol Pharm. 1995. PMID: 8960271 Review.
-
Opioids in chronic pain.Eur J Pharmacol. 2001 Oct 19;429(1-3):79-91. doi: 10.1016/s0014-2999(01)01308-5. Eur J Pharmacol. 2001. PMID: 11698029 Review.
-
A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.Neurobiol Dis. 1996 Feb;3(1):87-96. doi: 10.1006/nbdi.1996.0009. Neurobiol Dis. 1996. PMID: 9173916
-
Mu-, delta-, kappa-opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments.Neurochem Int. 1994 May;24(5):401-26. doi: 10.1016/0197-0186(94)90089-2. Neurochem Int. 1994. PMID: 7647696 Review.
Cited by
-
Epigenetics of µ-opioid receptors: intersection with HIV-1 infection of the central nervous system.J Cell Physiol. 2012 Jul;227(7):2832-41. doi: 10.1002/jcp.24004. J Cell Physiol. 2012. PMID: 22034138 Free PMC article. Review.
-
Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1).Br J Pharmacol. 2015 Jan;172(2):349-63. doi: 10.1111/bph.12644. Epub 2014 Jul 1. Br J Pharmacol. 2015. PMID: 24527749 Free PMC article. Review.
-
Expression and purification of functional human mu opioid receptor from E.coli.PLoS One. 2013;8(2):e56500. doi: 10.1371/journal.pone.0056500. Epub 2013 Feb 21. PLoS One. 2013. PMID: 23437147 Free PMC article.
-
Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor.Br J Pharmacol. 2009 Sep;158(1):225-31. doi: 10.1111/j.1476-5381.2009.00310.x. Epub 2009 Jul 7. Br J Pharmacol. 2009. PMID: 19594755 Free PMC article.
-
Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro.Br J Pharmacol. 2014 Sep;171(18):4273-88. doi: 10.1111/bph.12785. Br J Pharmacol. 2014. PMID: 24846673 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials